RxDoctor Payments Data

Jacob Elkins, MD

Orthopaedic Surgery · Iowa City, IANPI 1194163972

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $9,900 of the $12,909 with a category attached, or 76.7%. 8 manufacturers reported payments, led by Medical Device Business Services, Inc. at 57.6% of the total. Reporting peaked in 2022 at $7,732 and has fallen 64.0% since, to $2,784 in 2025.

$12,909in general payments, 2019–2025

Across 62 payments — averaging $208.22 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medical Device Business Services, Inc.$7K
  • Depuy Synthes Products, Inc.$3K
  • Johnson & Johnson$2K
  • Zimmer Biomet$605
  • Smith+Nephew$271
  • Stryker$195
  • plus $69 from 2 others
$174,740in research payments, 2019–2025

Across 141 payments — averaging $1239.29 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Depuy Synthes Products, Inc.$175K

What the payments were for

  • Consulting fees$9,90077%
  • Travel & lodging$290%
  • Food & beverage$2,98123%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$12,909 in reported general payments places this provider in the 85th percentile of 219 orthopaedic surgery providers in Iowa.

See all orthopaedic surgery providers in Iowa

Medicare billing

Part B allowed, 2024
$179,310
Medicare patients
245
Services billed
459

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Meloxicam17$23

Paid to pharmacies, not to this prescriber.

Other orthopaedic surgery in Iowa City

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →